Pritzker Private Capital Completes Acquisition of KabaFusion
CHICAGO--(BUSINESS WIRE)--Jan 24, 2019--Pritzker Private Capital today announced the acquisition of KabaFusion, a leading provider of acute and specialty home infusion services. Pritzker Private Capital is investing alongside KabaFusion’s pharmacist-led management team, who will continue to lead the business.
Headquartered in Cerritos, California, KabaFusion was founded in 2010 by Sohail Masood, Pharm D., a pioneer in immunoglobulin infusion with over 25 years of experience in home infusion services. With its seven fully accredited specialty pharmacies, the company serves patients with a broad range of acute and chronic conditions in more than 40 states, specializing in intravenous immunoglobulin (IVIG) and other home infusion therapies.
“We are committed to providing our patients with the highest quality of specialty home infusion treatments and are thrilled to partner with Pritzker Private Capital,” said Dr. Masood, KabaFusion CEO. “We selected Pritzker Private Capital because of their deep experience in healthcare services and differentiated long-term approach to building world-class businesses.”
“KabaFusion is a great example of a clinician-led company that puts patient care first,” said Tony Pritzker, Chairman and CEO of Pritzker Private Capital. “KabaFusion’s exceptional leadership team has decades of experience serving patients. Their commitment to excellence perfectly aligns with our core values.”
Michael Dal Bello, Pritzker Private Capital Investment Partner, said, “KabaFusion is a leader in IVIG and home infusion due to its patient-focused service model and clinical expertise. We are delighted to partner with Dr. Masood and the KabaFusion management team and look forward to supporting the company’s continued growth.”
Terms of the transaction were not disclosed.
About KabaFusion: KabaFusion was founded by Dr. Sohail Masood, Pharm D., in 2010 and operates seven fully accredited home infusion specialty pharmacies strategically located in California, Florida, Illinois, Massachusetts, New Jersey, Pennsylvania and Texas. KabaFusion is guided by a commitment to positive clinical outcomes and excellence in specialty acute and immunoglobulin infusion. The company is dedicated to working proactively with patients, healthcare practitioners and payers to provide comprehensive support before, during and after treatment. For more information, visit KabaFusion.com.
About Pritzker Private Capital: Pritzker Private Capital acquires and operates middle-market companies based in North America with leading positions in the manufactured products, services and healthcare sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. For more information, visit PPCPartners.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190124005124/en/
CONTACT: Martha Arendt,Aileron Communications
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA ILLINOIS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL PROFESSIONAL SERVICES FINANCE
SOURCE: Pritzker Private Capital
Copyright Business Wire 2019.
PUB: 01/24/2019 06:00 AM/DISC: 01/24/2019 06:01 AM